Goldman Sachs Group »

Affimed Therapeutics B V shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Affimed Therapeutics B V shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Affimed Therapeutics B V

Tip: Access up to 7 years of quarterly data

All positions including Affimed Therapeutics B V held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Affimed Therapeutics B V by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $17k 27k 0.63
2023-09-30 $27k 56k 0.48
2023-06-30 $184k 308k 0.60
2023-03-31 $194k 260k 0.75
2022-12-31 $1.1M 916k 1.24
2022-06-30 $1.6M 562k 2.77
2022-03-31 $4.6M 1.1M 4.37
2021-12-31 $8.7M 1.6M 5.52
2021-09-30 $18M 2.8M 6.18
2021-03-31 $18M 2.3M 7.91
2020-12-31 $11M 1.9M 5.82
2020-09-30 $924k 272k 3.39
2020-06-30 $1.4M 305k 4.62
2019-12-31 $994k 363k 2.74
2019-09-30 $2.0M 680k 2.94
2019-06-30 $327k 114k 2.87
2019-03-31 $68k 16k 4.22
2018-09-30 $111k 26k 4.35
2018-06-30 $36k 22k 1.67
2018-03-31 $20k 11k 1.81
2017-12-31 $14k 11k 1.27
2017-09-30 $67k 30k 2.24
2017-06-30 $81k 39k 2.06
2017-03-31 $104k 45k 2.30
2016-12-31 $173k 96k 1.80
2016-09-30 $149k 54k 2.77
2016-06-30 $155k 62k 2.48
2016-03-31 $59k 16k 3.72
2015-12-31 $223k 31k 7.13
2015-09-30 $69k 11k 6.17